Abstract Women with gestational diabetes have a high risk of type 2 diabetes postpartum, with Indigenous women particularly affected. This study reports postpartum diabetes screening rates among Indigenous and non-Indigenous women with gestational diabetes, in Far North Queensland, Australia. Retrospective study including 1,012 women with gestational diabetes giving birth at a regional hospital from 1/1/2004 to 31/12/2010. Data were linked between hospital records, midwives perinatal data, and laboratory results, then analysed using survival analysis and logistic regression. Indigenous women had significantly longer times to first oral glucose tolerance test (OGTT) [hazards ratio (HR) 0.62, 95 % confidence interval (CI) 0.48-0.79, p \ 0.0001) and 'any' postpartum glucose test (HR 0.81, 95 % CI 0.67-0.98, p = 0.03], compared to non-Indigenous women. Postpartum screening rates among all women were low. However, early OGTT screening rates (\6 months) were significantly lower among Indigenous women (13.6 vs. 28.3 %, p \ 0.0001), leading to a persistent gap in cumulative postpartum screening rates. By 3 years postpartum, cumulative rates of receiving an OGTT, were 24.6 % (95 % CI 19.9-30.2 %) and 34.1 % (95 % CI 30.6-38.0 %) among Indigenous and nonIndigenous women, respectively. Excluding OGTTs in previous periods, few women received OGTTs at 6-24 months (7.8 vs. 6.7 %) or 2-4 years (5.2 vs. 6.5 %), among Indigenous and non-Indigenous women, respectively. Low rates of postpartum diabetes screening demonstrate that essential 'ongoing management' and 'equity' criteria for population-based screening for gestational diabetes are not being met; particularly among Indigenous women, for whom recent guideline changes have specific implications. Strategies to improve postpartum screening after gestational diabetes are urgently needed.
Introduction
Gestational diabetes mellitus (gestational diabetes), defined as diabetes diagnosed during pregnancy [1, 2] , is increasing in prevalence [3, 4] . Indigenous women experience particularly high rates of gestational diabetes [4] [5] [6] , with Indigenous Australian women experiencing approximately twice the age-adjusted risk of gestational diabetes than other Australian women [4, 7] . Gestational diabetes causes serious complications in pregnancy, birth [8] and the longer term [9] for both women and their infants. Women diagnosed with gestational diabetes have a very high risk of developing type 2 diabetes mellitus (type 2 diabetes) postpartum (approximately 25 % within 15 years) [10] , more than seven-times the risk among women without gestational diabetes [11] , with Indigenous women having the highest risk [5, 12] . This emergence of diabetes among young child-bearing women represents an ominous stage in the diabetes epidemic, as exposure to diabetes in utero compounds the risk for the next generation [13, 14] , and gestational diabetes becomes an additional driver for type 2 diabetes [14, 15] .
Strong evidence about the risks associated with diabetes in pregnancy [8] has led to changes to international [2] and national [16] screening guidelines for gestational diabetes. The changes include: offering screening in early pregnancy for women at high risk of type 2 diabetes, in addition to 24-28 weeks as is currently recommended; separating 'probable' undiagnosed type 2 diabetes from gestational diabetes; and changing the diagnostic thresholds. These changes are likely to significantly increase the prevalence of gestational diabetes [17] , and have particular implications for Indigenous women, who are categorised as having a high risk of type 2 diabetes, and therefore advised to have additional screening in early pregnancy. Essential criteria when introducing population-based screening include ensuring that adequate and acceptable treatment, prevention and 'ongoing management' postpartum are provided, and that 'equity and access is provided' [18, 19] . There currently is limited evidence that these criteria are met [20] , particularly for Indigenous women [21] .
Despite the clear evidence of an increased risk of developing type 2 diabetes [5, 12, 22] , few studies have investigated rates of postpartum glucose screening for Indigenous women with gestational diabetes [21] , which has been identified as a 'high priority research need for gestational diabetes' [23] . In Far North Queensland, Australia, there have been a number of initiatives introduced to improve care for women with gestational diabetes [24] , including protocols [25] [26] [27] which recommend all women with gestational diabetes are offered postpartum glucose testing. While there is some variation in the recommendations during the study period from 2004 to 2010, the local guidelines are broadly based on the previous national guidelines [28] , which advise an early oral glucose tolerance test (OGTT) at 6-8 weeks postpartum, and then one to three yearly, dependent on assessment of risk and likelihood of pregnancy. This study describes rates of postpartum diabetes screening among Indigenous and non-Indigenous women with gestational diabetes in Far North Queensland from 1/1/ 2004 to 31/12/2010. Low rates of postpartum screening have been reported among non-Indigenous women in Australia [29] and internationally [30] ; with particularly low rates reported among Indigenous women in similar high income countries, including Canada [31] , and New Zealand [32, 33] . One small study recently reported low rates of postpartum screening among Indigenous women in Far North Queensland [34] . This study is timely with recent changes to national diabetes screening guidelines [16] , which have particular implications for Indigenous women. To our knowledge, this is the first study to compare rates of postpartum glucose screening among Indigenous and nonIndigenous women diagnosed with gestational diabetes.
Comparison is important to understand whether current strategies are similarly effective for all women, or whether targeted strategies for Indigenous women may be warranted.
Methods

Study Setting and Sample
The study setting and design details are reported elsewhere [35] . The study includes all women coded as giving birth at Cairns Hospital (CH) from 1/1/2004 to 31/12/2010 and having gestational diabetes in the CHCCS. CH is the regional hospital for Far North Queensland, a vast region covering almost 300,000 square kilometres. More than 80 % of women in the region give birth at CH, which includes almost all women with gestational diabetes as this is the only secondary referral hospital (resourced to provide care for most complicated pregnancies) in Far North Queensland. Gestational diabetes screening procedures and diagnostic criteria used during the study period are detailed elsewhere [36] .
The current study used linked electronic data with a sample validated by medical record reviews (MRR). The following data sources were linked: (1) [36] . For women identified with gestational diabetes in the CHCCS, data on all pregnancies during the study period were collected, to enable censoring during subsequent pregnancies, or following type 2 diabetes diagnosis.
The primary outcomes were: Time from gestational diabetes confinement date to the first OGTT or 'any' laboratory-based glucose test, including OGTT, glycosated haemoglobin (HbA1C), fasting plasma glucose (FPG), or random plasma glucose (RPG); and proportions of Indigenous and non-Indigenous women who had received a glucose test (OGTT or 'any') within three time windows which include recommended screening timepoints common to most screening guidelines; 6 weeks (0-6 months), 1 year (6-24 months), 3 years (2-4 years) postpartum. Point-of-care postpartum glucose tests (HbA1C, FPG, RPG) conducted at community-based healthcare services are not included. As an ethical requirement, where recommended postpartum glucose screening tests were due, letters were sent to the local medical practitioner to suggest that they check their records and assess the need to contact the woman and offer her a postpartum OGTT. The sample size was assessed as adequate to test the estimated 10 % difference in postpartum screening between Indigenous (20 %) and non-Indigenous women (30 %).
Data Analysis
De-identified data were analysed in Stata 11.0 statistical package (Stata Corporation, College Station, TX). Time to first glucose screening test from confinement date, among pregnancies coded as GDM, was summarised using Kaplan-Meier survival curves and analysed using Cox proportional hazards regression models. Separate models were fitted for time to OGTT and time to 'any' screening. Women were censored from the analysis if they became pregnant or were diagnosed with T2DM as they would then not be advised to have T2DM screening. Timing of pregnancy censoring events were from: time of onset of subsequent pregnancy, calculated as 273 days prior to subsequent confinement; or 20 weeks prior to date of a postpartum test if that test was coded as 'during pregnancy' yet no pregnancy was recorded, including all tests after 1/3/ 2010 to account for women who may be pregnant during the study period but give birth after the study period (31/ 12/2010). Timing of T2DM censoring events were from the date of T2DM diagnosis from any data source (e.g. medical records, MPDC data, laboratory tests) that indicated the woman had developed T2DM. The proportions of women screened by each of the recommended time points were assessed by calculating the proportion of eligible women who received an OGTT or 'any' laboratory-based screening test at the postpartum periods (0 to \ 6 months, 6 to \ 24 months, 24-48 months), excluding tests performed in the previous period. Tests were two tailed and p \ 0.05 was considered statistically significant. 1,010 women included in this study had 1,503 births during the study period and 1,083 births were coded as gestational diabetes after linkage with MPDC data and medical record review of 912 pregnancies, among 702 women. Overall, 6.2 % pregnancies were reclassified as gestational diabetes, from 65.4 % (596/912) before MRR to 71.6 % (653/912) after MRR using the MPDC coding (see Fig. 1 ). If a 6.2 % increase were extrapolated to the remaining 593 pregnancy records which were not reviewed, we would expect to have reclassified an additional 37 pregnancies as gestational diabetes.
The mean maternal age was 30.5 years (standard deviation (SD) 6.8) among Indigenous mothers and 33.2 (SD 5.6) among non-Indigenous mothers, while the mean BMI was 30.9 (SD 7.0) among Indigenous mothers and 29.1 (SD 6.7) among non-Indigenous mothers. Among the women who had a MRR, about half of Indigenous mothers had discharge referrals for their postpartum care to government health clinics (52 %), with substantial fractions to private medical practitioners (25 %), and community controlled health services (18 %). The majority of non-Indigenous mothers had discharge referrals to private medical practitioners (84 %), with small proportion at government health clinics (9 %). Selected characteristics of mothers and their pregnancies are outlined in Tables 1 and 2 .
Laboratories identified 1,625 glucose tests provided between 1/1/2004 and 31/11/2011 for the women included in this study; 1,067 (66 %) were follow-up screening tests and the remainder were during pregnancy or prior to a diagnosis of gestational diabetes. 342/1,067 (32 %) were provided for Indigenous women and 725/1,067 (68 %) were provided for non-Indigenous women.
Time to First OGTT
Significantly longer times to first OGTT were seen among Indigenous women, compared to non-Indigenous women [hazards ratio (HR) 0.62, 95 % CI 0.48-0.79, p \ 0.0001, Fig. 2a ; Table 3 ]. At 2 months postpartum, we estimated 7.9 % (95 % CI 5.6-11.1 %) Indigenous women and 16.8 % (95 % CI 14.2-19.8 %) non-Indigenous women had an OGTT recorded ( Table 4 ). The discrepancy in early screening rates led to a persistent gap between Indigenous and non-Indigenous women, for example by 3 years the cumulative rates of having received an OGTT postpartum, were 24.6 % (95 % CI 19.9-30.2 %) and 34.1 % (95 % CI 30.6-38.0 %) respectively (Table 4) .
Time to First Laboratory-Based Glucose Screening Test
We found a significantly longer time to 'any' laboratorybased postpartum glucose screen for Indigenous women, compared to non-Indigenous women (HR 0.81, 95 % CI 0.67-0.98 %, p = 0.03, Fig. 2b ; Table 3 ). At 2 months (Table 4) . By 36 months (3 years) postpartum, the cumulative rate of a first glucose screening test was starting to converge for the two populations, with 44.4 % (95 % CI 38.7-50.6 %) among Indigenous women, and 49.1 % (95 % CI 45.1-53.2 %) among non-Indigenous women (see Fig. 2b ; Table 4 ). Table 3 ). By 6 months postpartum, only 13.6 % (95 % CI 10.5-17.5 %) Indigenous women, compared to 28.3 % (95 % CI 25.1-31.9 %) non-Indigenous women received an OGTT ( Fig. 3a ; Table 5 ).
However, no significant difference was seen in the proportions of Indigenous and non-Indigenous women who received an OGTT at 12 months (6-24 months) and 3 years (24-48 months) postpartum, which encompasses the recommendations in most guidelines (Table 3) . Excluding OGTTs performed prior to 6 months postpartum; by 2 years postpartum 7.8 % (95 % CI 5.2-11.5 %) Indigenous women and 6.7 % (95 % CI 4.9-9.0 %) non-Indigenous women received an OGTT ( Fig. 3b ; Table 5 ). Excluding OGTTs performed prior to 24 months (2 years) postpartum; only 5.2 % (95 % CI 2.5-10.7 %) Indigenous women and 6.5 % (95 % CI 4.3-9.8 %) non-Indigenous women received an OGTT by 4 years postpartum ( Fig. 3c ; Table 5 ). Fig. 3d ; Table 5 ). However, when excluding glucose screening tests from the previous period, no significant differences were observed in the proportion of Indigenous and non-Indigenous women who received any laboratory-based postpartum glucose screen between 6 and 24 months or 2-4 years (Table 3) . Excluding tests performed prior to 6 months; by 2 years postpartum, 21. Fig. 3f ; Table 5 ).
Sensitivity analyses conducted with data restricted only to records which had a MRR (n = 910) were very similar to the results reported on the whole sample, with the exception of a wider confidence interval in the HR for any postpartum test at 6 months possibly leading to a different conclusion (HR 0.82, 95 % CI 0.65-1.03, p = 0.08). 
Discussion
We found that postpartum glucose screening rates were low among all women with gestational diabetes. These findings demonstrate that essential 'ongoing management' criteria for gestational diabetes screening are not being met. Further, significantly longer times were observed to first OGTT (HR 0.62) and 'any' (HR 0.81) postpartum glucose screen among Indigenous women, compared to non-Indigenous women. Early postpartum OGTT screening rates (\6 months) were significantly lower among Indigenous women (14 vs. 28 %), which led to a persistent gap in the cumulative rates of postpartum OGTT screening, demonstrating 'equitable access' to postpartum screening is also not being provided for Indigenous women, who are the subject of recent guideline recommendations [2, 37] . A limitation of this study includes the absence of 'point of care' tests provided by primary health care professionals, such as HbA1C, RPGs, and FPGs. Therefore the 'any laboratory-based test' estimates in this study are likely to be lower than the true glucose screening rates. Nevertheless, OGTTs are not performed outside a laboratory setting and therefore we conclude the rates of postpartum OGTT screening are accurate. Another limitation is that the medical record review suggested the identification of gestational diabetes is likely to be underestimated in these routinely collected data by approximately 37 pregnancies. Probability of testing 2  7  0  2  1  4  0  2  Indigenous   2  6  1  6   382  347  325  307   684  568  496  477  353  313  246  195   664  602  510  430  4   382  343  317  294   684  552  476  447  353  305  226  172   664  573  469  362  7  2  2  6  4 Therefore our estimates are likely be conservative and err towards overestimation of screening rates, with more pregnancies censored as 'not gestational diabetes'. Low rates of postpartum screening for type 2 diabetes have been reported for non-Indigenous women in Australia [29] and internationally [38, 39] , and similarly reported significant variations by ethnicity [40] . However, the rates of 14 % postpartum screening among Indigenous women by 6 months postpartum observed in our study, were significantly lower than the rates of 38 % by 6 weeks postpartum reported in Canada in 1998 [31] , and 37 % reported among Maori and non-Maori women more recently in New Zealand [32] . The only other study to date to report postpartum diabetes screening among Indigenous women in Australia, also in Far North Queensland during the same study period, noted that OGTTs were performed in 1/6 (16.6 %) Indigenous women diagnosed with gestational diabetes in 2006, and 6/19 (31.6 %) Indigenous women diagnosed with gestational diabetes in 2008 [34] . The variation from our study is likely due to small numbers.
The particularly low rates of early postpartum screening among Indigenous women, is a concern for a number of reasons. Indigenous women generally have higher parity than non-Indigenous women [41] , with shorter pregnancy intervals, therefore delays in postpartum screening may have greater consequences. Studies overseas suggest Indigenous women at highest risk of glucose intolerance may be less likely to return for postpartum diabetes screening [42] . Delayed diagnosis and treatment of type 2 diabetes also pose serious risks to subsequent pregnancies in the short term for both Indigenous and non-Indigenous women, including congenital abnormalities [43, 44] , shoulder dystocia, macrosomia [13, 45] , neonatal intensive care admissions, and hypoglycaemia [46] [47] [48] ; and increased risks for the infant in the longer term of obesity, hyperglycaemia, type 2 diabetes and renal disease [14, [49] [50] [51] [52] [53] [54] . Undiagnosed and untreated diabetes also poses serious risks for the mother, including caesarean section [55] , heart disease, stroke, renal disease, kidney failure, limb amputations and blindness [56] .
The reasons for low rates of postpartum screening among Indigenous women are not yet well-understood, and research is required to improve our understanding to systematically develop strategies to improve postpartum screening. Surveys of non-Indigenous women and providers elsewhere have reported a number of barriers to postpartum screening [29, 57, 58] . Reported barriers include factors such as: lack of awareness and forgetting about the need for a test, test inconvenience, the unpleasant nature of the test and the fear of results [58] , poor communication, time pressures, costs, inconsistent guidelines, and lack of GDM documentation [40] . While little is known about barriers for Indigenous women, one study suggests low health literacy among Indigenous people in Far North Queensland in relation to diabetes [59] , which is likely to impede the decision-making capacity of women with gestational diabetes. There is evidence of disparities in access to treatment for the complications of diabetes [60] [61] [62] [63] [64] [65] , including diabetes in pregnancy [66] , which may be helpful for understanding some of the barriers to postpartum glucose screening among Indigenous women with gestational diabetes. Women in Far North Queensland also experience additional challenges, including long distances to travel to receive an OGTT, real or perceived costs associated with tests from limited private laboratory services, high staff turnover, and high population mobility. Another challenge is the number of guidelines which address cardio-metabolic risk screening among Indigenous people, who may fall under several 'risk' categories [67] [68] [69] [70] [71] [72] . Most guidelines recommend regular glucose screening, however only gestational diabetes guidelines advise an OGTT be used as a screening test, rather than a diagnostic test; as both FPG and HbA1C have lower sensitivity and may not detect impaired glucose tolerance [73] [74] [75] . Even during the short period of this study, local guidelines changed three times [25] [26] [27] , with some variation from national guidelines [28] , and have subsequently been revised twice [76] , broadly in line with revised national guidelines [37] . Recent studies show that comparatively simple 'interventions' can improve postpartum glucose screening rates [77] , including physician reminders [78] , system changes [31, 73, 79] , proactive postpartum care plans [80] , antenatal education [81] , registers [82] , clinical protocols, electronic records and patient reminders [83] . One study in the United States showed stark comparisons between high rates of early postpartum Papanicolaou (Pap) testing for cervical cancer (94 %), and concurrent low rates of postpartum glucose screening among women with GDM (37 %) [84] . Successful strategies to improve cervical cancer screening among Indigenous women [85] , which includes a national register and reminder system, may provide lessons to improve postpartum screening.
Importantly, gestational diabetes can be treated [86] [87] [88] and the rate of progression to type 2 diabetes reduced [89] ; therefore a gestational diabetes diagnosis offers an important 'window of opportunity' [90] for prevention, and strategies to improve postpartum glucose screening must also include supporting women to reduce and manage their risks. Recent studies suggest the 'pre-diabetes' stage presents a critical opportunity for prevention of type 2 diabetes [91] . While the evidence for effective strategies for preventing type 2 diabetes among Indigenous peoples' is scarce [92] , studies among non-Indigenous women suggest postpartum weight loss is achievable, and the postpartum period offers unique preventive opportunities for women [93, 94] and their infant [95, 96] by breastfeeding; and through strategies involving diet and exercise [97] [98] [99] [100] [101] . Women with gestational diabetes, and their infants, are more likely to experience interventions and complications during pregnancy and birth which may inhibit breastfeeding, such as caesarean section and neonatal hypoglycaemia, and therefore are likely to require additional support postpartum. Further, Indigenous women are more likely to be categorised as having as having 'low socio-economic status', which is associated with a lower confidence with breastfeeding [102] and postpartum weight loss [103] , suggesting positive encouragement and support may be helpful.
These findings support calls for targeted programs to address the needs of women in specific cultural groups [40] to ensure all women with gestational diabetes receive postpartum glucose screening. Further research is needed to investigate factors associated with postpartum glucose screening, to identify practical collaborative solutions with communities to overcome barriers. Tailoring support in response to local needs will require qualitative formative and/or participatory action research, and careful evaluation, to ensure the benefits of recent changes to international gestational diabetes screening recommendations are realised and outweigh the risks and inconvenience.
Conclusions
While postpartum glucose screening rates are low for all women in Far North Queensland, the early postpartum glucose screening rates are particularly low among Indigenous women. Essential population-based screening criteria to ensure 'ongoing management' and 'equitable access' for recently introduced guidelines, which have particular implications for Indigenous women, are not being met. This issue is particularly serious for Indigenous women, who already have a much higher risk of type 2 diabetes compared to non-Indigenous women.
